SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-22-000075
Filing Date
2022-11-07
Accepted
2022-11-07 07:07:17
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnce-20220930.htm   iXBRL 10-Q 1778038
2 EX-31.1 q32022exhibit311.htm EX-31.1 10680
3 EX-31.2 q32022exhibit312.htm EX-31.2 10646
4 EX-32.1 q32022exhibit321.htm EX-32.1 6153
5 EX-32.2 q32022exhibit322.htm EX-32.2 6078
  Complete submission text file 0001367920-22-000075.txt   7316543

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20220930.xsd EX-101.SCH 43978
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20220930_cal.xml EX-101.CAL 56644
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20220930_def.xml EX-101.DEF 226415
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20220930_lab.xml EX-101.LAB 576855
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20220930_pre.xml EX-101.PRE 381091
60 EXTRACTED XBRL INSTANCE DOCUMENT cnce-20220930_htm.xml XML 1147036
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 221363692
SIC: 2834 Pharmaceutical Preparations